You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for NDC 00054-0528


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00054-0528

Drug NameNDCPrice/Unit ($)UnitDate
RUFINAMIDE 40 MG/ML SUSPENSION 00054-0528-63 0.30919 ML 2025-04-23
RUFINAMIDE 40 MG/ML SUSPENSION 00054-0528-63 0.28508 ML 2025-03-19
RUFINAMIDE 40 MG/ML SUSPENSION 00054-0528-63 0.26676 ML 2025-02-19
RUFINAMIDE 40 MG/ML SUSPENSION 00054-0528-63 0.30773 ML 2025-01-22
RUFINAMIDE 40 MG/ML SUSPENSION 00054-0528-63 0.38871 ML 2024-12-18
RUFINAMIDE 40 MG/ML SUSPENSION 00054-0528-63 0.41392 ML 2024-11-20
RUFINAMIDE 40 MG/ML SUSPENSION 00054-0528-63 0.51368 ML 2024-10-23
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 7 of 7 entries

Best Wholesale Price for NDC 00054-0528

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
RUFINAMIDE 40MG/ML SUSP,ORAL Golden State Medical Supply, Inc. 00054-0528-63 460ML 1003.12 2.18070 2023-06-23 - 2028-06-14 FSS
RUFINAMIDE 40MG/ML SUSP,ORAL Golden State Medical Supply, Inc. 00054-0528-63 460ML 961.52 2.09026 2023-06-15 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 2 of 2 entries

Market Analysis and Price Projections for the Drug NDC: 00054-0528

Understanding the NDC Code

The National Drug Code (NDC) 00054-0528 is a unique identifier for a specific drug product. This 10-digit code is segmented into three parts: the labeler code, the product code, and the package code. For the NDC 00054-0528, here is a breakdown:

  • Labeler Code: 00054, which identifies the company that manufactures or distributes the drug.
  • Product Code: 0528, which specifies the strength, dosage form, and formulation of the drug.
  • Package Code: This segment identifies the package size and type[1][5].

Market Trends in the Pharmaceutical Industry

To analyze the market and project prices for the drug identified by NDC 00054-0528, it is crucial to understand current trends in the pharmaceutical industry.

Dominance of Small Molecule Drugs and Biologics

In 2024, small molecule drugs continue to dominate the market, although there is a growing adoption of biologics. This shift can impact pricing and market dynamics, as biologics often come with higher price tags due to their complex manufacturing processes and higher development costs[3].

Personalized Medicine and AI

The increasing use of AI in pharmaceuticals is driving demand for personalized medicine, which could influence pricing strategies as drugs become more tailored to individual needs. This trend may lead to higher costs due to the specialized nature of these treatments[3].

Outsourcing and Contract Manufacturing

Outsourcing of drug development and manufacturing to Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs) is on the rise. This can help reduce costs and improve efficiency but may also affect pricing due to the varying costs associated with different service providers[3].

Drug Price Inflation

According to Vizient's summer 2024 Pharmacy Market Outlook, the overall drug price inflation rate for pharmaceuticals is projected to be 3.81% in 2025. This projection is influenced by factors such as the expanding indications of previously approved medications and the introduction of high-cost cell and gene therapies[2].

Pricing Standards and NDC Codes

NDC codes play a critical role in pricing and billing. The pricing of drugs identified by NDC codes is based on several standards, including the conversion factors that help in pricing the applicable billings. These standards ensure accurate payment and control of drug costs[1].

Global Pricing Comparisons

The United States has significantly higher drug prices compared to other regions. For instance, the average price per unit in the U.S. was 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world in 2022. This disparity highlights the complex pricing landscape in the U.S. pharmaceutical market[4].

Specific Drug Pricing: NDC 00054-0528

To project the price of the drug identified by NDC 00054-0528, several factors need to be considered:

Current Pricing

The current price of the drug can be determined by referring to the FDA's National Drug Code Directory or other pricing databases. This will provide a baseline for any future projections.

Market Demand and Supply

Changes in demand, driven by factors such as new indications or increased usage, can significantly impact pricing. For example, the increased spend on semaglutide (up 77% since the summer 2023 Outlook) due to its expanded indications is a clear example of how demand can drive price increases[2].

Regulatory and Technological Changes

Regulatory shifts, advancements in technology, and the integration of AI in drug development can influence pricing. For instance, personalized medicine and biologics may command higher prices due to their specialized nature and complex development processes[3].

Economic Factors

Economic conditions, including inflation rates and global market trends, also play a role in drug pricing. The projected 3.81% drug price inflation rate for 2025 is a key indicator of how prices might trend in the near future[2].

Projected Price Trends

Given the current trends and factors influencing the pharmaceutical market:

  • Short-Term Projections: For the next year, the price of the drug identified by NDC 00054-0528 is likely to increase in line with the overall drug price inflation rate of 3.81% projected by Vizient.
  • Long-Term Projections: Over the next few years, the price could be influenced by the adoption of new technologies, changes in regulatory environments, and shifts in market demand. If the drug falls under the category of biologics or personalized medicine, it may experience higher price increases compared to small molecule drugs.

Key Takeaways

  • NDC Codes: Critical for identifying and pricing drugs accurately.
  • Market Trends: Dominance of small molecule drugs, growing adoption of biologics, and increasing use of AI in pharmaceuticals.
  • Price Inflation: Projected at 3.81% for 2025, influenced by expanding indications and new therapies.
  • Global Pricing: U.S. prices are significantly higher than in other regions.
  • Regulatory and Technological Changes: Impact pricing through advancements in technology and regulatory shifts.

FAQs

Q: What is the significance of the NDC code in drug pricing? A: The NDC code ensures accurate identification and pricing of drugs, helping in correct payment and control of drug costs.

Q: How does the adoption of biologics affect drug pricing? A: Biologics often come with higher price tags due to their complex manufacturing processes and higher development costs.

Q: What is the projected drug price inflation rate for 2025? A: According to Vizient, the projected drug price inflation rate for 2025 is 3.81%.

Q: Why are drug prices in the U.S. higher than in other regions? A: Drug prices in the U.S. are higher due to a combination of higher prices for the same drugs and a drug mix that skews towards more expensive compounds[4].

Q: How does AI influence drug pricing? A: AI drives demand for personalized medicine, which can lead to higher costs due to the specialized nature of these treatments.

Sources

  1. AAPC: NDC Code Lookup - CPT/HCPCS Cross-Reference
  2. Vizient Inc.: Vizient projects drug price inflation at 3.81%
  3. Global Pharma Tek: Top 12 Pharmaceutical Industry Trends in 2024
  4. ASPE: ISSUE BRIEF - International Market Size and Prices
  5. FDA: National Drug Code Directory

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.